Pages
Clay Cross Hospital
https://dchs.nhs.uk/our-services-and-locations/our-locations/community-hospitals/clay-cross-hospital
Rainbow lanyard awareness posters
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/rainbow-lanyard-awareness-posters
DCHS Chair Julie visits Okeover Ward
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-chair-julie-visits-okeover-ward
Files
A2 British Heart Foundation Exercise Video and Strength - Booklet 3 (S109)
British Heart Foundation Exercise Video and Strength - Booklet 3
Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
PGD Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
Guidance for Wound Clinic Services for the use of tap water on chronic wounds (G308)
Guidance for Wound Clinic Services for the use of tap water on chronic wounds
Annual Leave Calculator 2024-2025
Annual Leave Calculator 2024-2025
DCHS Scheme Of Delegation
Scheme Of Delegation - April 2025
A2 - Catheter Clinical Appointment Letter (G324)
Catheter Clinical Appointment Letter
Disclosure Ref 2024131 - Cyber Security Attacks.pdf
FOI Disclosure Ref 2024131 relating to Cyber Security Attacks
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010